#United States #Milwaukee #Medical College of Wisconsin #TBI Rehabilitation #Avalon Action Alliance

Innovative Clinical Trial for Traumatic Brain Injury Rehabilitation

In a groundbreaking endeavor that promises to transform the standard of care for traumatic brain injuries (TBI), the Medical College of Wisconsin (MCW) is leading a significant multi-center clinical trial aimed at improving the rehabilitation of military veterans and first responders coping with mild traumatic brain injuries and associated mental health issues. Under the auspices of the Avalon Action Alliance, this initiative, titled the Veteran's Interdisciplinary Care for TBI and co-Occurring disorders Rehabilitation Trial (VICTORY-RCT), represents one of the most comprehensive research studies in TBI rehabilitation to date.

A Critical Need Addressed

Despite an increasing acknowledgment of the profound effects of TBIs, including lifelong challenges stemming from concussions and brain traumas, many affected individuals struggle to find effective and coordinated treatment. The recent developments in this trial come as a beacon of hope, aiming to standardize and enhance access to interdisciplinary rehabilitation practices across the nation.

MCW, located in Milwaukee, will serve as the primary coordinating site for this ambitious study, with Dr. Michael McCrea, a distinguished expert in TBI, helming the research efforts. As a professor and vice chair of Neurosurgery, as well as the interim executive director of the Wisconsin Institute of NeuroScience, Dr. McCrea's involvement underscores the trial's scientific credibility and significance.

Major Funding and Support

A generous $7.5 million clinical trial agreement provided by the Avalon Action Alliance marks a substantial investment in the mission to advance evidence-based rehabilitation for veterans and first responders. This funding is set to support the study over the coming four years, signifying a deep commitment to addressing the ongoing challenges faced by those with TBIs and other related disorders.

The VICTORY-RCT aims to explore the effectiveness of a novel three-week intensive outpatient rehabilitation program that will be implemented across five participating clinical sites, each affiliated with Avalon Action Alliance. By coordinating these efforts, the trial seeks to gather substantial evidence on the efficacy and durability of rehabilitation models tailored specifically for individuals experiencing TBIs.

An Holistic Approach to Treatment

MCW has recently introduced the trial as part of its BRAVE program, the only comprehensive treatment center in the Midwest dedicated to addressing TBI, PTSD, and other psychological injuries that impact the lives of veterans and first responders. In addition to MCW, the trial involves collaboration with other esteemed institutions such as:

• - University of North Carolina at Chapel Hill – THRIVE Program
• - University of Florida Health Jacksonville – Leon L. Haley Jr., MD, Brain Wellness Program
• - University of Colorado Anschutz – Marcus Institute for Brain Health
• - Jefferson Health – MossRehab Institute for Brain Health

Changing the Narrative on TBI Rehabilitation

Joel Brennan, the CEO of Avalon Action Alliance, remarked on the purpose behind this initiative: “Avalon was created to ensure veterans and first responders can access the right care at the right time.” He further emphasized that the VICTORY-RCT reflects a vital step forward in fortifying clinical evidence surrounding comprehensive TBI rehabilitation, ultimately aiming to improve patient access to care and cultivate more effective treatment standards.

The outcomes of this ambitious trial may not only enhance rehabilitation practices for military veterans and first responders but could also have a broad impact on civilian populations affected by TBI. As the study unfolds, all eyes will be on the Medical College of Wisconsin and its collaborative partners, pivotal players in pioneering a future where those with brain injuries receive the most effective and informed care available.

For more information about this landmark trial and ongoing developments, you can visit MCW's official news website.